what are glp-1 agonists America's Poison Centers Current Insights, Advantages and Challenges
Description
A small trial including 8 patients with T1D showed improved postprandial hyperglycemia despite 20% insulin dose reduction (69)
This is referred to as the mesolimbic dopamine pathway, or reward pathway
McClean, P
Active GLP-1 concentrations in portal vein significantly increased at 0.5 h and plateaued at 1 and 2 h after oral administration of d-allulose (1 g kg 1 ), returning to baseline at 3 h (Fig
doi:10.1016/j.xops.2024.100547 23
